Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.imfinzihcp.com/
- Competitors
- Entyvio (vedolizumab), TAGRISSO® (osimertinib) HCP, XYWAV® (calcium, magnesium, potassium, and sodium oxybates), ZEPZELCA® (lurbinectedin) HCP, ZERBAXA® (ceftolozane and tazobactam) HCP, PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) HCP, OPDIVO® (nivolumab) US HCP, ENHERTU® (fam-trastuzumab deruxtecan-nxki) HCP, KEYTRUDA® (pembrolizumab) HCP, KISQALI HCP.